Evaluation of tele-expertise in the management of common dermatoses in peripheral health centers in Togo from 2018 to 2023

Panawé Kassang1,2, Bayaki Saka1,2, Abas Mouhari-Touré1,2, Sefako Akakpo1,2, Julienne Teclessou1,2, Emilie Lauressergues3, Christophe Przybylski3, Piham Gnossike1,2, Garba Mahamadou1, Léa Matel3, Raymond Barruet1, Claude Akakpo1, Koussake Kombate1,2, Béatrice Garrette3, Kissem Tchangai-Walla1, Palokinam Pitche1,2

1Togolese Society of Dermatology and Sexually Transmitted Infections (SOTODERM), Lomé, Togo, 2Skin and Environment Research Laboratory, University of Lomé, Lomé, Togo, 3Pierre Fabre Foundation, Lavaur, France

Corresponding author: Panawé Kassang, MD, E-mail: panawekassang@gmail.com

How to cite this article: Kassang P, Saka B, Mouhari-Touré A, Akakpo S, Teclessou J, Lauressergues E, Przybylski C, Gnossike P, Mahamadou G, Matel L, Barruet R, Akakpo C, Kombate K, Garrette B, Tchangai-Walla K, Pitche P. Evaluation of tele-expertise in the management of common dermatoses in peripheral health centers in Togo from 2018 to 2023. Our Dermatol Online. 2025;16(3):237-241.
Submission: 11.03.2025; Acceptance: 24.05.2025
DOI: 10.7241/ourd.20253.3

Citation tools: 

Related Content

Copyright information

© Our Dermatology Online 2025. No commercial re-use. See rights and permissions. Published by Our Dermatology Online.


ABSTRACT

Background: Tele-expertise in dermatology represents an avenue for modifying medical practice in response to the needs of health economics. The aim of this study was to evaluate the medical activities of the tele-expertise project implemented over a five-year period by the Togolese Society of Dermatology (SOTODERM).

Material and methods: This was a single-pass, cross-sectional evaluation conducted between July and August 2023 on project sites during field visits by SOTODERM’s expert dermatologists. The main targets of this evaluation were site agents and their activities on the tele-expertise platform.

Results: In the course of this survey, 70 of the 100 health agents, including 82.9% paramedics, were evaluated on 47 sites. On these 47 sites, dermatoses represented 2% of all reasons for consultation. Of the dermatoses received in consultations, 2231 cases were sent to the remote expertise platform (Bogou). The profile of the dermatoses received in consultation was similar to that of cases sent to Bogou. For the 1854 of the 2231 cases where a single diagnosis was evoked, there was diagnostic concordance in 837 cases (45.1%) between the health worker and the expert dermatologist. The main challenge was the poor availability of dermatological drugs on the sites.

Conclusion: Togo’s dermatology tele-expertise project has had a positive impact on the accessibility and quality of dermatological care provided by non-dermatologist health workers. However, there are still challenges in terms of access to dermatological drugs within the framework of universal access to care.

Key words: teledermatology; tele-expertise; dermatology; SOTODERM, Togo


INTRODUCTION

Telemedicine is a medical practice that uses information and communication technologies (ICT) to provide distance medical services [1]. This innovative approach to providing distance healthcare services has developed around the world generally because of a shortage of healthcare personnel and in the face of specific challenges, which vary according to geographical area [2]. The COVID-19 pandemic has generally forced healthcare systems around the world to adopt this approach as an effective solution for ensuring continuity of care [3,4]. Depending on the geographical area of the world, telemedicine is adopted as a solution to difficulties in providing quality care to populations difficult to access for reasons such as geographical isolation, natural disasters, wars, and sociopolitical and security crises [57]. In developing countries, teledermatology is, therefore, one of the most widely adopted approaches to telemedicine [7,8]. Teledermatology projects have been set up in recent years in countries in the sub-Saharan sub-region, notably Ghana [9], Mali [10], Côte d’Ivoire [11], and Burkina Faso [12]. In Togo, a teledermatology project was set up in 2018 by the Togolese Society of Dermatology and Sexually Transmitted Infections (SOTODERM) with financial support from the Pierre Fabre Foundation (FPF). The project was implemented in two main phases: a pilot phase between 2018 and 2020, with encouraging results [13], followed by a generalization phase from 2020 to 2023. At the end of five years of this project, it is important to assess the impact of tele-expertise in dermatology on the management of common skin conditions in Togo. The objectives of the present study were to assess the impact of tele-expertise on the quality of dermatosis management by health workers in peripheral health centers and to identify the profile of these dermatoses and the challenges encountered.

MATERIALS AND METHODS

Description of Project Implementation Stages

The teledermatology project was initiated in Togo in 2018 by SOTODERM with financial support from the Pierre Fabre Foundation.

Pilot phase

The pilot phase of the project involved forty agents from twenty peripheral centers chosen on the basis of criteria, the most important of which was the distance from the furthest town where a dermatologist could be found. Two main activities were undertaken during the pilot phase: i) production of a national guide to the management of common dermatoses drawn up by a group of experts; ii) training of the forty health agents based on the content of this guide; iii) training in the taking of images of dermatoses and the use of the tele-expertise platform. The pilot phase, which took place between 2018 and 2020, was the subject of an evaluation, which showed encouraging data and enabled the transition to the generalization phase [13].

Generalization phase

The generalization phase, following the pilot phase, retained the same principles yet with several improvements based on lessons learned from the pilot phase. The project grew from twenty centers to fifty, and from forty to one hundred health agents. The new agents were also trained in the various aspects of the project. In terms of technical innovation, the camera was replaced by the smartphone for taking photographs, reducing the workload of the agents. This generalization phase covered a three-year period from 2020 to 2023.

Type, Period, and Scope of the Study

This was a descriptive, cross-sectional study that took place in July 2023 at the teledermatology sites set up in Togo since the project began in 2018.

The study was conducted on 47 of the 50 teledermatology sites throughout the country. The three centers that were not included in the study were areas declared unsafe by the political authorities due to terrorist attacks recorded there in the months preceding our study or due to accessibility problems.

Inclusion criteria

All health workers present at their posts at the time of the study were included in the study.

Data Collection

Data collection was performed by seven referring dermatologists using survey forms. To limit information bias, the investigators were distributed so that no dermatologist collected data on the sites for which he or she was responsible for responding to requests for expert reports.

In each center, two types of data were collected: data collected from the respondents and data collected from the registers and expertise form.

Data Collected

During a face-to-face interview, data was collected on the quality and response times of the expert.

Data on the ability to diagnose and correctly manage common dermatoses was collected by presenting photographs of common dermatoses and noting the percentage of correct diagnoses evoked by the agent, as well as the therapeutic prescriptions proposed by the agent.

Data collected on expertise sheets and registers:

  • Expertise form: This was a form that the agent filled in with the clinical details of each patient for whom tele-expertise was requested. These forms were used to collect data on diagnoses, expert response times, and the number of tele-expertise requests. Qualitative data was collected from center managers and a number of patients met on the study sites.
  • Registry: Data on the center’s activities (number of consultations of all types, number of dermatological consultations, types of dermatological conditions).
  • Bogou platform, on which images were posted by health workers: number and type of conditions posted.

Data Processing and Statistical Analysis

Data entry was performed using EPI Data software, version 3.1. Data was, then, exported for statistical analysis using STATA, version 15.1. For continuous variables, means and standard deviations were calculated, while categorical variables were presented in absolute frequencies and proportions.

Ethics Statement

All patients seen in our study gave verbal consent.

RESULTS

Health Centers and Agents

Our study involved 47 (94%) of the 50 teledermatology sites set up by the project. A total of 70 (70%) of the 100 agents present at the 50 teledermatology project sites were included in our study, 82.9% of whom were paramedics (nurses, medical assistants, midwives).

The agents’ diagnostic skills were assessed by presenting them with photographs (between 5 and 10) of common dermatoses. In all, 64 (91.4%) of the health-care workers scored above the benchmark for good diagnostic ability (finding more than half the diagnoses in this diagnostic quality assessment exercise). All agents mentioned the non-availability of the majority of prescribed drugs from their centers’ in-house pharmacies.

Activities on the Bogou Platform

During the period from June 2020 to July 2024 (generalization phase), 2231 cases requesting expertise were sent to the Bogou teledermatology platform by agents at the 47 sites included in our study.

The average response time was 40 hours (1.67 days), with a minimum of 2 minutes and a maximum of 1,694 hours (70.6 days). The mean age of the patients was 29 years, and the sex ratio (female-to-male) was 1.2. The average duration of evolution of the dermatoses for which the patients consulted was 17 days. In 15.1% of the cases, no diagnostic hypothesis was suggested by the agents. In 86% of cases, the expert made a definite diagnosis (Table 1). For the 1854 cases where only one diagnosis was made, there was a concordance diagnosis between the expert’s and the agent’s diagnoses in 837 cases (45.1%).

Table 1: Key data from tele-expertise activity on the Bogou platform (n=2231).

Of the 2231 cases of dermatoses referred to the Bogou platform during the study period by the 70 agents evaluated, 90.9% (1958 patients) were managed on site and 9.1% (197 patients) were referred. Of the 1958 patients managed on site, more than half (59.2%; 1,160 patients) were never seen again. Of the 798 patients reviewed, 616 (77.2%) were cured of their dermatosis.

Superficial cutaneous mycoses, pyoderma and contact dermatitis were the top three dermatoses out of the top ten dermatoses for which expert opinion was sought (Table 2).

Table 2: Main dermatoses posted on the Bogou platform in descending order.

Taking into account all types of consultations on the 47 sites (380088 consultations) in our study, dermatosis accounted for 2% (15505) of consultations or visits to these centers.

DISCUSSION

The main strength of our study was that it was not limited to collecting data on the tele-expertise platform, but also enabled us to collect data from the various actors involved in the remote care supply chain, as well as data from consultation registers, in order to put the results obtained into perspective. In addition, one of the original features of this project was the capacity-building of health agents, both upstream through training and the provision of a management guide (with iconography and management algorithms), and downstream through the supervision of these agents by dermatosis referents. Data from this evaluation confirmed the positive impact of tele-expertise on access to dermatological care in resource-limited countries [1416].

The average response time after a request for expertise in our study was around forty hours. This compares with 22.16 hours during the pilot phase of a Togolese teledermatology project [13], and 32 hours in the pilot phase of a study by Faye et al. in Mali [10]. With the generalization phase, the number of centers has risen from 20 (pilot phase) to 50 centers, with a significant increase in the number of tele-expertise requests. This could explain the increase in response times by dermatologist experts, whose numbers had not changed since the pilot phase.

The ten main dermatoses for which expert reports were requested were, in descending order, superficial cutaneous mycoses, pyoderma, contact eczema, prurigo, erysipelas, scabies, urticaria, chickenpox, atopic dermatitis, acne. The profile of these dermatoses is virtually the same in hospitals in Togo as in other countries in the West African sub-region [10,13,17,18]. This profile confirms the preponderance of infectious dermatoses and the emergence of immunoallergic dermatoses in Africa.

The results obtained in the implementation of this project showed that teledermatology, or tele-expertise, is a good strategy for improving the quality of dermatological care in peripheral care centers, with a significant impact on resolving the problems of geographical accessibility for populations. Yet, the constraints to improving care remain the permanent unavailability of trained agents and dermatological drugs in the country’s peripheral centers.

CONCLUSION

The results obtained in the implementation of the tele-expertise project in dermatology in Togo document the positive impact on the quality of services offered by non-dermatologist health workers on the one hand and the increase in the population’s geographical accessibility to dermatological care on the other. The strategy of tele-expertise in healthcare provision is a good prospect for developing countries suffering from a chronic shortage of quality healthcare personnel. There are still, however, challenges to be overcome in terms of access to dermatological medicine for the population as part of universal access to care.

ACKNOWLEDGMENTS

We would like to thank all those involved in this project and the Pierre Fabre Foundation for its financial support.

Statement of Human and Animal Rights

All the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the 2008 revision of the Declaration of Helsinki of 1975.

Statement of Informed Consent

Informed consent for participation in this study was obtained from all patients.

REFERENCES

1.Boudjema K, Simon P, Moulin T, Pon D, Chays A, VouhéP. [Good practices in telemedicine]. Bull Acad Natl Med. 2022;206:657-9.

2.Parizel É, Marrel P, Wallstein R. La télémédecine en questions. Études. 2013;419:461-72.

3.Byravan S, Fardanesh A, Tahir H, Moorthy A. Digital health strategies in the war against COVID-19 and beyond. Br J Hosp Med Lond Engl 2005. 2020;81:1-3.

4.Yeboah CB, Harvey N, Krishnan R, Lipoff JB. The impact of COVID-19 on teledermatology:A review. Dermatol Clin. 2021;39:599-608.

5.Alrifai A, Alyousef T, Fanari Z. Tele-cardiology in the Syrian War. J Am Coll Cardiol. 2018;71:698-9.

6.Merrell RC, Cone SW, Rafiq A. Telemedicine in extreme conditions:Disasters, war, remote sites. Stud Health Technol Inform. 2008;131:99-116.

7.Coustasse A, Sarkar R, Abodunde B, Metzger BJ, Slater CM. Use of Teledermatology to improve dermatological access in rural areas. Telemed J E-Health Off J Am Telemed Assoc. 2019;25:1022-32.

8.Hadeler EK, Beer J, Nouri K. Teledermatology:Improving access or widening healthcare disparities?J Drugs Dermatol JDD. 2020;19:1248.

9.Osei-tutu A, Shih T, Rosen A, Amanquah N, Chowdhury M, Nijhawan RI, et al. Mobile teledermatology in Ghana:Sending and answering consults via mobile platform. J Am Acad Dermatol. 2013;69:90-91.

10.Faye O, Bagayoko CO, Dicko A, CisséL, BerthéS, TraoréB, et al. A teledermatology pilot programme for the management of skin diseases in primary health care centres:Experiences from a resource-limited country (Mali, West Africa). Trop Med Infect Dis. 2018;3:88.

11.Yotsu RR, Itoh S, Yao KA, Kouadio K, Ugai K, Koffi YD, et al. The early detection and case management of skin diseases with an mhealth app (eskinhealth):Protocol for a mixed methods pilot study in Côte d’Ivoire. JMIR Res Protoc. 2022;11:39867.

12.Caumes E, Le Bris V, Couzigou C, Menard A, Janier M, Flahault A. Dermatoses associated with travel to Burkina Faso and diagnosed by means of teledermatology. Br J Dermatol. 2004;150:312-6.

13.Saka B, Mouhari-Toure A, Akakpo S, Teclessou J, Lauressergues E, Przybylski C, et al. [Evaluation of the tele-expertise project in the management of common dermatoses in Togo]. Sante Publique Vandoeuvre–Nancy Fr. 2023;35:211-9.

14.Peracca SB, Fonseca A, Hines A, King HA, Grenga AM, Jackson GL, et al. Implementation of Mobile teledermatology:Challenges and opportunities. Telemed J E-Health Off J Am Telemed Assoc. 2021;27:1416-22.

15.Massone C, Javor S, Amato I, Biondo G, Brunasso AMG, Hofmann-Wellenhof R. Training of primary care physicians enhances performance of mobile teledermatology. An Bras Dermatol. 2021;96:514-6.

16.Lam M, Doiron PR. The use of teledermatology in medical education. Med Sci Educ. 2022;32:243–6.

17.Akakpo AS, Teclessou JN, Kassang P, Mouhari-Toure A, Kombate K, Saka B, et al. Profil des dermatoses en consultation foraine en milieu rural au Togo. J Rech Sci L’UniversitéLomé. 2021;23:231-6.

18.Fofana Y, Traore B, Dicko A, Faye O, Berthe S, Cisse L, Keita A, Tall K, Kone MB, Keita S. [Epidemio-clinical profile of dermatoses in children receiving dermatological consultation in the Department of Dermatology at the National Center for Disease Control in Bamako (Mali)]. Pan Afr Med J. 2016;25:238.

Notes

Source of Support: This article has no funding source.

Conflict of Interest: The authors have no conflict of interest to declare.

Copyright by authors of this article. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Request permissions
If you wish to reuse any or all of this article please use the e-mail (contact@odermatol.com) to contact with publisher.

Related Content:

Related Articles Search Authors in

http://orcid.org/0000-0001-9687-6928
http://orcid.org/0000-0002-8889-2693
http://orcid.org/0009-0006-1029-2555
http://orcid.org/0000-0002-5844-0856
http://orcid.org/0000-0003-2619-8396
http://orcid.org/0000-0003-2812-0568
http://orcid.org/0009-0005-3450-8886
http://orcid.org/0009-0008-6171-9541
http://orcid.org/0000-0001-8645-1176
http://orcid.org/0009-0008-6087-403X
http://orcid.org/0000-0003-2617-1636
http://orcid.org/0009-0009-5723-0476
http://orcid.org/0000-0001-7858-7049

Rights and permissions

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Comments are closed.